317 results on '"Ronsisvalle, Simone"'
Search Results
2. Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment
3. Harmaline and Human ClpP Activation for Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) Treatment
4. Aerosol Emissions from Heated Tobacco Products: A Review Focusing on Carbonyls, Analytical Methods, and Experimental Quality
5. Evaluation of Crocin Content and In Vitro Antioxidant and Anti-Glycation Activity of Different Saffron Extracts
6. In Vitro Evaluation of Antioxidant and Anti-Glycation Activity of Crocin from Different Saffron Extracts
7. Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile
8. 1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity
9. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting
10. Different In Silico Approaches Using Heterocyclic Derivatives against the Binding between Different Lineages of SARS-CoV-2 and ACE2
11. Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy
12. Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists
13. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain
14. Chemical, Antioxidant and Biological Studies of Brassica incana subsp. raimondoi (Brassicaceae) Leaf Extract
15. Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells
16. Evaluation of N-substituent structural variations in opioid receptor profile of LP1
17. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives
18. Formulation of germinated brown rice fermented products functionalized by probiotics
19. Orobanche crenata Forssk. Extract Affects Human Breast Cancer Cell MCF-7 Survival and Viral Replication
20. DSC investigation of the effect of the new sigma ligand PPCC on DMPC lipid membrane
21. From NMDA receptor antagonists to discovery of selective σ2 receptor ligands
22. Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes
23. Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research
24. Evaluation of educational seminar on the analysis of pesticides in cannabis
25. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand
26. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment
27. Anti-Candidal Activity of the Parasitic Plant Orobanche crenata Forssk
28. Identification of a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells
29. The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation
30. Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain
31. Evaluation of N-substitution in 6,7-benzomorphan compounds
32. Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection
33. Involvement of the Nociceptin/Orphanin FQ-NOP receptor system in the ventrolateral periaqueductal gray following mechanical allodynia in chronic pain
34. Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence
35. Antimicrobial, Antioxidant, and Cytotoxic Activities of Juglans regia L. Pellicle Extract
36. A new sigma ligand, (±)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect
37. The multitarget opioid ligand LP1ʼs effects in persistent pain and in primary cell neuronal cultures
38. Identification of a Potent and Selective 5-HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
39. Pharmacological properties and biochemical mechanisms of μ-opioid receptor ligands might be due to different binding poses: MD studies
40. In-silico design and biological investigations of Diabetic Neuropathy modulators: could MOR become a focal mediator for this pathology?
41. Pharmacological properties and biochemical mechanisms of MOR ligands might be due to different binding poses. MD Studies
42. Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures
43. Natural Flavones and Flavonols: Relationships among Antioxidant Activity, Glycation, and Metalloproteinase Inhibition
44. Quantum Chemical and Molecular Dynamics Studies of MUC1 Calix[4,8]arene Scaffold Based Anticancer Vaccine Candidates
45. Effects of intraplantar Nocistatin and (±)-J 113397 injections on nociceptive behavior in a rat model of inflammation
46. Antibacterial and anti-biofilm activities of walnut pellicle extract (Juglans regia L.) against coagulase-negative staphylococci
47. Anti-amnesic properties of (±)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats
48. Antimicrobial activity of Juglans regia L. pellicle extract
49. IDENTIFICATION OF POTENT 1,3-DIOXOLANE-BASED 5-HT1A RECEPTOR AGONISTS FOR THE TREATMENTS OF CNS DISORDERS AND PAIN
50. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.